Clinical Trials
4
Active:0
Completed:4
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile
Phase 2
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- Micropharma Limited
- Target Recruit Count
- 10
- Registration Number
- NCT02216825
Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
Phase 2
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Micropharma Limited
- Target Recruit Count
- 150
- Registration Number
- NCT01630668
- Locations
- 🇨🇦
KGK Synergize Inc., London, Ontario, Canada
Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation
Phase 2
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2011-04-26
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Micropharma Limited
- Target Recruit Count
- 131
- Registration Number
- NCT01341613
- Locations
- 🇨🇿
APharma s.r.o., Prague, Czech Republic
Efficacy of Cardioviva™ Probiotic Yogurt Formulation
Phase 2
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2012-07-02
- Lead Sponsor
- Micropharma Limited
- Target Recruit Count
- 150
- Registration Number
- NCT01185795
News
No news found